Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Accelerates Revenue Momentum As Amvuttra Expands Market Access
![]() |
Alnylam shows accelerating commercial traction while technical indicators signal reduced trend strength and potential near-term downside pressure. Fundamental strength in margins and cash balances supports the valuation assigned by WMDST. |









